25 results
8-K
EX-10.1
KPTI
Karyopharm Therapeutics Inc.
14 May 24
Other Events
4:06pm
Expenses
Indemnity
Set-Off
Amendments and Waivers
Successors and Assigns; Participations
Independence of Covenants
Survival of Certain Agreements
No Waiver … .
10.7 Independence of Covenants. All covenants hereunder shall be given independent effect so that if a particular action or condition
8-K
EX-99.1
KPTI
Karyopharm Therapeutics Inc.
4 May 23
Karyopharm Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
7:53am
overall survival was 8.7 months in both populations. The transfusion independence rate for red blood cells and/or platelets was 29%. The prognosis
PRE 14A
m7w4z p33ku
2 Apr 19
Preliminary proxy
4:29pm
8-K
EX-10.1
z6awjawa he
17 Aug 18
Entry into a Material Definitive Agreement
4:01pm